Residents of Philadelphia, Pennsylvania, can now access Tirzepatide (Mounjaro / Zepbound) through Weight Method's fully virtual weight loss program. The fast-paced Northeastern lifestyle — long commutes, demanding schedules, and winters that limit outdoor activity — makes medically supported weight loss especially practical. Tirzepatide is prescribed by licensed providers and shipped directly to your Philadelphia address.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Philadelphia is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Philadelphia, PA. Weight Method offers compounded tirzepatide, prescribed by licensed providers, from $329/month with virtual consultations and direct-to-door shipping.
Tirzepatide works by mimicking incretin hormones that your body naturally produces after eating. It activates receptors in the brain that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. For Philadelphia residents, Weight Method makes its compounded Tirzepatide program accessible through telehealth — a virtual consultation with a licensed provider, your prescription shipped to your door, and ongoing clinical support. Individual response varies, and your provider sets expectations based on your clinical profile rather than on brand-product trial figures.
In a fast-moving city like Philadelphia, time is the scarcest resource. Tirzepatide requires just one weekly injection and periodic virtual check-ins with your Weight Method provider — no recurring clinic visits, no disruption to your routine. Your medication arrives at your Philadelphia address, and clinical trials show 20-25% of body weight average weight loss, giving urban professionals a realistic path to results.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Pennsylvania and start Tirzepatide from $329/month.
Get Started NowFree consultation. No commitment.